Gillian Harvey

Prof. Gillian Harvey

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
SMSarah Munce
Sarah Munce
CGCarolyn Steele Gray
Carolyn Steele Gray
BPBeverley Claire Pomeroy
Beverley Claire Pomeroy
MBMark Theodore Bayley
Mark Theodore Bayley
KKKristina Kokorelias
Kristina Kokorelias
KKKerry Kuluski
Kerry Kuluski
Background: There is increasing evidence that co-design can lead to more engaging, acceptable, relevant, feasible, and even effective interventions. However, no guidance is provided on the specific designs and associated methods or methodologies involved in the process. We propose the development of the Preferred Components for Co-design in Research (PRECISE) guideline to enhance the consistency, transparency, and quality of reporting co-design studies used to develop complex health interventions. Objective: The aim is to develop the first iteration of the PRECISE guideline. The purpose of the PRECISE guideline is to improve the consistency, transparency, and quality of reporting on studies that use co-design to develop complex health interventions. Methods: The aim will be achieved by addressing the following objectives: to review and synthesize the literature on the models, theories, and frameworks used in the co-design of complex health interventions to identify their common elements (components, values or principles, associated methods and methodologies, and outcomes); and by using the results of the scoping review, prioritize the co-design components, values or principles, associated methods and methodologies, and outcomes to be included in the PRECISE guideline. Results: The project has been funded by the Canadian Institutes of Health Research. Conclusions: The collective results of this project will lead to a ready-to-implement PRECISE guideline that outlines a minimum set of items to include when reporting the co-design of complex health interventions. The PRECISE guideline will improve the consistency, transparency, and quality of reports of studies. Additionally, it will include guidance on how to enact or enable the values or principles of co-design for meaningful and collaborative solutions (interventions). PRECISE might also be used by peer reviewers and editors to improve the review of manuscripts involving co-design. Ultimately, the PRECISE guideline will facilitate more efficient use of new results about complex health intervention development and bring better returns on research investments. International Registered Report Identifier (IRRID): PRR1-10.2196/50463

4 May 2021 in Design for Health
Verified
Journal Article
Closed access
GHGillian Harvey
Gillian Harvey
KBKatherine Bubric
Katherine Bubric
SVStephanie VandenBerg
Stephanie VandenBerg
HHHeather Hair
Heather Hair
This paper discusses a multi-method approach of gathering data in order to understand how variables within a high stress environment, such as a hospital emergency room, can affect user experience. The challenges facing emergency departments in Alberta can be summarized as a lack of understanding of what happens in an emergency room, inadequate communication between staff and the public, and challenges with the physical design of these departments. Through this study we were able to understand the patient experience and to identify gaps in service, gain insights into issues that are negatively impacting patients and suggests artefacts and processes in order to better deliver patient care.

1 July 2021 in The Journal of Health Design
Verified
Journal Article
Open access
PDF file
GHGillian Harvey
Gillian Harvey
MKMichelle Knox
Michelle Knox
EHElaine Hyshka
Elaine Hyshka
ARAidan Rowe
Aidan Rowe
LLLianne Lefsrud
Lianne Lefsrud
MFMary Forhan
Mary Forhan
The distribution of Naloxone kits has revealed the need for alternative ways to get training, kits, and education to individuals at risk of overdose. An interdisciplinary study explored barriers to adopting and using Naloxone kits and found several opportunities to use design methods to identify and address barriers.

17 July 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
MMMaryam Mallakin
Maryam Mallakin
JLJoe Langley
Joe Langley
GHGillian Harvey
Gillian Harvey
SWSarah Walker
Sarah Walker
CRCaylee Raber
Caylee Raber
KSKate Sellen
Kate Sellen
Background: The COVID-19 pandemic significantly transformed the landscape of work and collaboration, impacting design research methodologies and techniques. Co-design approaches have been both negatively and positively affected by the pandemic, prompting a need to investigate and understand the extent of these impacts, changes, and adaptations, specifically in the health sector. Despite the challenges that the pandemic imposed on conducting co-design and related projects, it also encouraged a re-evaluation of co-design practices, leading to innovative solutions and techniques. Designers and researchers have explored alternative ways to engage stakeholders and end users, leveraging digital workshops and participatory digital platforms. These adaptations have the potential to enhance inclusivity, allowing for a wider range of individuals to contribute their perspectives and insights through co-design and thus contribute to healthcare change. Objective: This study aims to explore the impacts of the pandemic on co-design and related practices, focusing on co-design practices in healthcare that have been gained, adapted, or enhanced, with a specific focus on issues of equity, diversity, and inclusion. Methods: The study uses a realist synthesis methodology to identify and analyze the effects of the pandemic on co-design approaches in health, drawing on a range of sources including first-person experiences, gray literature, and academic literature. A community of practice in co-design in health will be engaged to support this process. Results: By examining the experiences and insights of professionals, practitioners, and communities who were actively involved in co-design and have navigated the challenges and opportunities of the pandemic, we can gain a deeper understanding of the strategies, tools, and techniques that have facilitated effective co-design during the pandemic, contributing to building resilience and capacity in co-design in health beyond the pandemic. Conclusions: By involving community partners, community of practice (research), and design practitioners, we expect closer proximity to practice with capacity building occurring through the realist process, thus enabling rapid adoption and refinement of new techniques or insights that emerge. Ultimately, this research will contribute to the advancement of co-design methodologies and inform the future of co-design in health. International Registered Report Identifier (IRRID): DERR1-10.2196/58318

4 November 2019 in Conference Proceedings of the Academy for Design Innovation Management
Verified
Journal Article
Open access
PDF file
GHGillian Harvey
Gillian Harvey
SVStephanie Vandenberg
Stephanie Vandenberg
The opioid crisis in Alberta is a public health crisis. In 2016, more people died from an opioid poisoning than from motor vehicle crashes. Naloxone is an opioid antagonist which means that it can reverse an opioid overdose for a period of 30–60 minutes, at which point, the overdose may return. In December 2015, the Take Home Naloxone (THN) Program was rolled out in response to the opioid crisis. Under the renamed the Community Based Naloxone Kit Program (CBNP), naloxone kits are now available free of cost at many pharmacies and community clinics around Alberta. The wide availability has led to a new challenge—that the kits may be used by people who have received little to no training.Some may encounter the kit instructions for the first time when there is an emergency in which they need to administer an injection urgently to someone who has passed out. Studies have found that most overdoses occur in the presence of another person—this provides an opportunity for someone to intervene. People often die from witnessed opioid poisonings because other people do not know what to do to help. A pilot study conducted through community partnerships involved 30 participants in two different urban centres (Edmonton and Calgary) who self identified as either experienced in substance use or friends/family of people with lived experience has revealed some interesting findings.Qualitative observations and data collected in the initial pilot work show that end users are experiencing unique challenges in accessing opioid education and have challenges using instructions on how to administer naloxone in an overdose setting. User testing and observation of user behavior has great potential to support educational material for opioid awareness.Human-centred design approaches that gather information with and about people using antidote kits are urgently needed in order to mitigate risk and ensure successful administration of first aid and naloxone in an emergency.

29 April 2026 in JMIR Preprints
Verified
Preprint
Open access
SMSarah Munce
Sarah Munce
UMUmair Majid
Umair Majid
JSJosh Shore
Josh Shore
DLDorothy Luong
Dorothy Luong
CGCarolyn Steele Gray
Carolyn Steele Gray
KKKerry Kuluski
Kerry Kuluski
BACKGROUND Co-design is a collaborative process spanning the lifecycle of a design project that uses creativity, reflexivity, and iterative learning to support feedback, adaptation, and shared understanding during intervention development. Co-design aims to involve diverse groups, including patients, caregivers, clinicians, administrators, community members, researchers, designers, and policy actors. Evidence suggests co-designed interventions may be more engaging, acceptable, and feasible to implement than those developed using traditional approaches. Despite the growing adoption of co-design, considerable variation remains in how it is understood, implemented, and reported, limiting its potential to support meaningful and equitable improvements in health interventions. OBJECTIVE To map the scope and nature of the literature describing the models, theories, and frameworks (MTFs) used to co-design complex health interventions and synthesize their key characteristics. This review constitutes Phase 1 of the Preferred Components for Co-design in Research (PRECISE) initiative, which aims to enhance conceptual clarity, methodological rigour, and transparency in reporting co-design studies for complex health interventions. METHODS A scoping review was conducted following JBI guidance and reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. Seven databases were searched from 1972 to 19 October 2023. Screening and data extraction were done independently and in duplicate. Publications were eligible if they reported co-design, co-production, or co-creation approaches and applied a model, theory, or framework to guide co-design of complex interventions. Extracted data were synthesized descriptively using counts and proportions. RESULTS A total of 130 publications were included. Co-design terminology use was inconsistent: 62.3% of publications used the term “co-design,” 7.7% “co-production”, 6.9% “co-creation”, and 16.2% did not use any co-approach term in their methodology. Among publications using a co-approach term, only 31.2% provided an associated citation. Fewer than two-thirds (60.0%) reported reciprocal collaboration with co-design partners. Among these, “developing the intervention” was the most commonly reported role (89.5%), while involvement in analysis and dissemination was less frequently reported. Reported co-design principles were variable, with "use participatory means" being the most prevalent (93.9%). Regarding MTFs, 70.0% of publications used a design-only MTF (e.g., pre-2021 Medical Research Council framework). Only three studies (2.3%) used a co-only MTF. Nearly half (42.3%) reported using a co + design MTF (e.g., Double Diamond). Of those using a co + design MTF, 67.3% operationalized its elements in the study context. CONCLUSIONS This scoping review reveals significant variability in how co-design is defined, conceptualized, and applied in the development of complex health interventions, with limited use of and application of MTFs. These findings highlight the necessity for clearer conceptual bases and more transparent reporting. As Phase 1 of the PRECISE guideline initiative, this review lays the empirical groundwork for developing reporting standards for co-design research. CLINICALTRIAL The Open Science Framework on June 12, 2023 (osf.io/prd3t).